Bruker (BRKR) Income towards Parent Company (2010 - 2026)
Bruker's (BRKR) quarterly Income towards Parent Company came in at -$51.0 million in Q2 2026, down 950.0% on a YoY basis from $6.0 million in Q2 2025, and down 431.17% quarter-over-quarter from $15.4 million in Q1 2026.
Analysis
Bruker (BRKR) Income towards Parent Company (2010 - 2026) Analysis & Trends
Bruker (BRKR) has reported Income towards Parent Company for 17 consecutive years, with -$51.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Income towards Parent Company fell 950.0% year-over-year to -$51.0 million; the trailing twelve-month figure through Jun 2026 stood at -$50.7 million (down 67.88% YoY), and the FY2025 full-year result was $8.0 million, up 107.05% from the prior year.
- Income towards Parent Company declined to -$51.0 million in Q2 2026 per BRKR's latest filing, from $15.4 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $98.5 million in Q4 2022 and bottomed at -$654.0 million in Q4 2023.
- Historically, Income towards Parent Company has averaged -$15.1 million across 5 years, with a median of $16.2 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Income towards Parent Company surged 247.16% in 2025, then sank 950.0% in 2026.
- Over 5 years, Income towards Parent Company stood at $98.5 million in 2022, then tumbled by 763.96% to -$654.0 million in 2023, then jumped by 98.04% to -$12.8 million in 2024, then plunged by 483.59% to -$74.7 million in 2025, then surged by 31.73% to -$51.0 million in 2026.
- According to Business Quant data, Income towards Parent Company over the past three periods registered -$51.0 million, $15.4 million, and -$74.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -51.00 Mn |
| Mar 31, 2026 | 15.40 Mn |
| Dec 31, 2025 | -74.70 Mn |
| Sep 30, 2025 | 59.60 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Dec 31, 2024 | -12.80 Mn |
| Sep 30, 2024 | -40.50 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -52.30 Mn |
| Dec 31, 2023 | -654.00 Mn |
| Sep 30, 2023 | 89.10 Mn |
| Jun 30, 2023 | 58.20 Mn |
| Mar 31, 2023 | 77.50 Mn |
| Dec 31, 2022 | 98.50 Mn |
| Sep 30, 2022 | 88.60 Mn |
| Jun 30, 2022 | 49.90 Mn |
| Mar 31, 2022 | 62.10 Mn |
| Dec 31, 2021 | 485.30 Mn |
| Sep 30, 2021 | -88.10 Mn |